Stryker reports strong financial results for 2017

Stryker has announced its financial results for the fourth quarter and full-year periods of 2017, during which the company achieved strong year-on-year growth.

For the full 12 months, the firm generated net sales of $12.4 billion (8.95 billion pounds) which represented an increase of 9.9 percent compared to 2016. For the fourth quarter, sales were up by ten percent to $3.5 billion.

This positive momentum was reflected across the company's orthopaedics, MedSurg and neurotechnology and spine business divisions, with the MedSurg unit delivering the largest proportion of sales.

Based on the encouraging performance achieved during 2017, Stryker now expects to deliver organic sales growth in the range of six to 6.5 percent for the 2018 business year.

Kevin Lobo, chairman and chief executive officer, said: "We expect our positive momentum to continue in 2018 with another year of strong organic sales growth and leveraged adjusted earnings gains."

With over 20 years of experience within the medical devices market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current medical device roles we have available, you can search for the latest job roles, register your details, or contact the team today.